A PK and Safety Study in Subjects With Hepatic Impairment
Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
Assess the single dose PK and safety of TR701 FA in subjects with Moderate or Severe hepatic
impairment versus matched control subjects with normal hepatic function.